Cdk5 on the brain

Cell Growth and Differentiation

Volumn 12, Issue 6, 2001, Pages 277-283

  Smith, D S ^a   Greer, P L ^a   Tsai, L H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 5; PHOSPHOTRANSFERASE; PROTEIN SERINE THREONINE KINASE;

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN; CELL MIGRATION; CYTOSKELETON; DEGENERATIVE DISEASE; ENZYME ACTIVITY; ENZYME REGULATION; EXTRACELLULAR SPACE; NERVE CELL; NERVE FIBER GROWTH; NEUROPATHOLOGY; NEUROSECRETION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; ANIMALS; AXONS; BRAIN; CELL MOVEMENT; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; HUMANS; NEURONS; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 0034913291     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Cloning of a human cDNA encoding a CDC2-related kinase by complementation of a budding yeast cdc28 mutation
2. A new human p34 protein kinase, CDK2, identified by complementation of a cdc28 mutation in Saccharomyces cerevisiae, is a homolog of Xenopus Eg1
3. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family
4. Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes
5. The cyclin-dependent kinase family
6. Expression of CDK5 (PSSALRE kinase), a neural cdc2-related protein kinase, in the mature and developing mouse central and peripheral nervous systems
7. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system
8. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5
9. A brain-specific activator of cyclin-dependent kinase 5
10. An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator
11. p39 activates cdk5 in neurons and is associated with the actin cytoskeleton
12. The crystal structure of cyclin A
13. A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator
14. Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality
15. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death
16. The origin and migration of cortical neurons: New vistas
17. Migration defects of cdk5(-/-) neurons in the developing cerebellum is cell autonomous
18. Temporal and spatial patterns of expression of p35, a regulatory subunit of cyclin-dependent kinase 5, in the nervous system of the mouse
19. Changes in the expression of novel Cdk5 activator messenger RNA (p39nck5ai mRNA) during rat brain development
20. Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system
21. The expression of Cdk5, p35, p39, and Cdk5 kinase activity in developing, adult, and aged rat brains
22. Synaptic localization of p39, a neuronal activator of cdk5
23. Callosal axon guidance defects in p35(-/-) mice
24. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation
25. The cyclin-dependent kinase Cdk5 controls multiple aspects of axon patterning in vivo
26. Two modes of radial migration in early development of the cerebral cortex
27. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene
28. The cadherin cytoplasmic domain is unstructured in the absence of β-catenin: A possible mechanism for regulating cadherin turnover
29. Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase
30. p35/cdk5 binds and phosphorylates β-catenin and regulates β-catenin/presenilin-1 interaction
31. Cables links Cdk5, and c-Abl, and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth
32. Dosage-sensitive modifiers of Drosophila abl tyrosine kinase function: Prospero, a regulator of axonal outgrowth, and disabled, a novel tyrosine kinase substrate
33. Enabled, a dosage-sensitive suppressor of mutations in the Drosophila Abl tyrosine kinase, encodes an Abl substrate with SH3 domain-binding properties
34. A role for Abl in Notch signaling
35. Dosage-sensitive, reciprocal genetic interactions between the Abl tyrosine kinase and the putative GEF trio reveal trio's role in axon pathfinding
36. Reelin is a ligand for lipoprotein receptors
37. Developmental neurobiology. Decoding the Reelin signal
38. Reeler/disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2
39. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler
40. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation
41. Proteins of the CNR family are multiple receptors for Reelin
42. Focal adhesions: Structure and dynamics
43. Analysis of the expression, distribution and function of cyclin dependent kinase 5 (cdk5) in developing cerebellar macroneurons
44. Integrin α1β1-mediated activation of cyclin-dependent kinase 5 activity is involved in neurite outgrowth and human neurofilament protein H Lys-Ser-Pro tail domain phosphorylation
45. Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth
46. Neuron-specific Cdk5 kinase is responsible for mitosis-independent phosphorylation of c-Src at Ser75 in human Y79 retinoblastoma cells
47. From Abl to actin: Abl tyrosine kinase and associated proteins in growth cone motility
48. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells
49. Integrin-mediated signals regulated by members of the rho family of GTPases
50. The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity
51. Desmosomes intercellular adhesive junctions specialized for attachment of intermediate filaments
52. Neurofilaments in health and disease
53. Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism
54. Kinesin-mediated transport of neurofilament protein oligomers in growing axons
55. Bidirectional translocation of neurofilaments along microtubules mediated in part by dynein/dynactin
56. Neurofilaments consist of distinct populations that can be distinguished by C-terminal phosphorylation, bundling, and axonal transport rate in growing axonal neurites
57. Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5
58. Presenilin-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia similar to human type 2 lissencephaly
59. NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein
60. Cadherin-mediated regulation of microtubule dynamics
61. Adenomatous polyposis coli (APC) protein moves along microtubules and concentrates at their growing ends in epithelial cells
62. The many faces of the tumor suppressor gene apc
63. A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system
64. Regulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1
65. Molecular motors. Keeping the beat
66. Kinesin and dynein superfamily proteins in organelle transport and cell division
67. Drosophila Lis1 is required for neuroblast proliferation, dendritic elaboration and axonal transport
68. Isolation of a Miller-Dieker lissencephaly gene containing G protein β-subunit-like repeats
69. Genetics of neuronal migration in the cerebral cortex
70. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons
71. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5
72. Site-specific phosphorylation of synapsin I by mitogen-activated protein kinase and Cdk5 and its effects on physiological functions
73. Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18
74. Amphiphysin binds the cdk5 regulatory subunit p35 and is phosphorylated by cdk5 and cdc2
75. Mouse cyclin-dependent kinase (Cdk) 5 is a functional homologue of a yeast Cdk, pho85 kinase
76. Mammalian Cdk5 is a functional homologue of the budding yeast Pho85 cyclin-dependent protein kinase
77. Cdk5 is involved in neuregulin-induced acetylcholine receptor expression at the neuromuscular junction
78. The role of cyclin-dependent kinase 5 and a novel regulatory subunit in regulating muscle differentiation and patterning
79. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
80. Neurotoxicity induces cleavage of p35 to p25 by calpain
81. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway
82. Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease
83. A "protease activation cascade" in the pathogenesis of Alzheimer's disease
84. Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis
85. From Charcot to SOD1. Mechanisms of selective motor neuron death in ALS
86. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons
87. Extra axonal neurofilaments do not exacerbate disease caused by mutant Cu, Zn super-oxide dismutase
88. Deregulation Cdk5 in a mouse model of ALS. Toxicity alleviated by perikaryal neurofilament inclusions